Fixed Dose Combination of two antibiotics: cefepime hydrochloride (a cephalosporin) and amikacin sulphate (an aminoglycoside) administered as a single product. The product is developed to overcome multi bacterial, complicated hospital acquired ICU infections particularly in deadly diseases like Nosocomial Pneumonia and Febrile Neutropenia.
Patent Granted in India, South Africa, and South Korea. Patent Pending in multiple other geographies
Technologies